ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced the launch of the Riskguard™ hereditary cancer test in the United ...

The American Cancer Society is adding three new colon cancer screening tests to its recommendations. The move is designed to get more people tested more regularly as rates of young people diagnosed ...

Those results seem to be consistent with broader research. One study shows AI-supported screening increased breast cancer ...

SAN DIEGO--(BUSINESS WIRE)--ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it has received UK Conformity Assessed (UKCA) ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

A Super Bowl ad used NFL tight ends to promote a finger-free prostate cancer screening. The ad, starring players like Rob Gronkowski, played heavily on humor to encourage men to get a PSA blood test.